# A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)

> **NCT07222098** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Metformin
- **DRUG:** Calderasib

## Key facts

- **NCT ID:** NCT07222098
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-11-19
- **Primary completion:** 2025-12-14
- **Final completion:** 2025-12-29
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07222098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07222098, "A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07222098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*